APP and Alzheimer disease: Because current models based on Amyloid toxicity do not provide a complete explanation for the onset of neuronal dysfunction in AD, it has long been argued that greater attention needs to shift towards understanding the normal physiological function of APP in order to assess its potential contribution to AD pathology [21],[22].